Biopolymers from Sugar Beet Molasses: Isolation, Characterization, and Bioactive Properties.
Crouse J., Sellers S., Wawrousek K., Sabino RM.
Laboratory Study, published in ACS Omega (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- ACS Omega (2025)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40191357
- PMCID
- PMC11966254
- DOI
- 10.1021/acsomega.4c09633
Abstract (original English)
Utilizing the natural biological properties of plant byproducts for a variety of applications presents the opportunity to combine nature's benefits with sustainable innovation. For this study, sugar beet molasses polymer (SBMP) was isolated from a byproduct of sugar beet processing. The SBMP was analyzed to determine its suitability for potential uses in biomedicine, cosmetics, and antimicrobial coatings. To determine whether the SBMP was indeed a polymer, MALDI-TOF MS was performed. The chemical composition of the SBMP was characterized using XPS, 1 H NMR, 13 C NMR, and FTIR. The characterization concluded that the SBMP contains phenolic and hydroxide groups. The presence of these groups was further supported by the SBMP's high antioxidant activity (∼80% RSA). The SBMP also demonstrated antimicrobial activity against Rhodococcus erythropolis (∼80% GI at 1 mg/mg SBMP), Escherichia coli (∼80% GI at 1 mg/mg SBMP), and Saccharomyces cerevisiae (∼38% GI at 1 mg/mg SBMP). Additionally, the SBMP showed no toxicity to human adipose-derived stem cells (ADSC) at concentrations up to 0.5 mg/mL and supported healthy cellular growth. Due to its strong antimicrobial and antioxidant activity, SBMP could be used in a variety of biomedical, cosmetic, and coating applications.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.